Ligand and Channel Therapeutics announce a merger to advance ZELSUVMI™, a new treatment for molluscum contagiosum, supported by $50 million in funding. Ligand Pharmaceuticals and Channel Therapeutics ...
(RTTNews) - Ligand Pharmaceuticals Inc. (LGND) Thursday announced a definitive merger agreement with Channel Therapeutics Corp.(CHRO) to combine Ligand's wholly owned subsidiaries, Pelthos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results